16.11

1.26% 0.20

Cellebrite Di Ltd (CLBT)

Overview News Price History Option Chain Discussions Forecast

Cellebrite Di Ltd stock is traded at $16.11, with a volume of 1.66M. It is up +1.26% in the last 24 hours and up +12.97% over the past month. Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.

Previous Close:

$15.91

Open:

$15.98

24h Volume:

1.66M

Relative Volume:

1.00

Market Cap:

$3.86B

Revenue:

$401.20M

Net Income/Loss:

$-283.01M

P/E Ratio:

-11.59

EPS:

-1.39

Net Cash Flow:

$121.56M

1W Performance:

+3.27%

1M Performance:

+12.97%

6M Performance:

-15.74%

1Y Performance:

-3.71%

1-Day Range:

$15.75

$16.23

1-Week Range:

$15.19

$16.34

52-Week Range:

$13.10

$26.30

Cellebrite Di Ltd Stock (CLBT) Company Profile

Name

Cellebrite Di Ltd

Sector

Technology (776)

Industry

Software - Infrastructure (164)

Phone

Address

Employee

1,167

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

CLBT's Discussions on Twitter

Compare CLBT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CLBT Cellebrite Di Ltd	16.11	3.95B	401.20M	-283.01M	121.56M	-1.39
MSFT Microsoft Corporation	507.23	3.84T	281.72B	101.83B	71.61B	13.64
ORCL Oracle Corp	236.37	699.60B	57.40B	12.63B	-394.00M	4.34
PLTR Palantir Technologies Inc	158.74	412.86B	3.44B	763.29M	1.71B	0.30
CRWD Crowdstrike Holdings Inc	420.55	106.26B	4.14B	-173.85M	1.03B	-0.69
SNPS Synopsys Inc	606.52	115.71B	6.21B	1.33B	1.09B	13.85

Cellebrite Di Ltd Stock (CLBT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-28-24	Reiterated	Needham	Buy
Mar-13-24	Upgrade	William Blair	Mkt Perform → Outperform
Feb-16-24	Upgrade	BofA Securities	Neutral → Buy
Jul-19-23	Initiated	Craig Hallum	Buy
Aug-12-22	Downgrade	BofA Securities	Buy → Neutral
Aug-12-22	Downgrade	William Blair	Outperform → Mkt Perform
Feb-24-22	Initiated	JP Morgan	Overweight
Feb-11-22	Initiated	Deutsche Bank	Buy
Dec-02-21	Initiated	BofA Securities	Buy
Oct-21-21	Initiated	Citigroup	Buy

View All

Cellebrite Di Ltd Stock (CLBT) Latest News

Aug 20, 2025

Cellebrite (CLBT) Fell Due to Below-Expected Outlook, but Core Trends Persist - Yahoo Finance

Aug 20, 2025

Aug 19, 2025

Cellebrite (CLBT) Fell on Investors’ Worry that US Federal Budget Uncertainty Could Delay Purchases - Yahoo Finance

Aug 19, 2025

Aug 18, 2025

Earnings Beat: Cellebrite DI Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - simplywall.st

Aug 18, 2025

Aug 17, 2025

Can Cellebrite DI Ltd. continue delivering strong returnsJuly 2025 WrapUp & Risk Managed Investment Entry Signals - thegnnews.com

Aug 17, 2025

Cellebrite DI Receives Positive Ratings from Deutsche Bank and Lake Street - AInvest

Aug 17, 2025

Aug 16, 2025

Cellebrite DI Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - 富途牛牛

Aug 16, 2025

Cellebrite DI Ltd. Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next - uk.finance.yahoo.com

Aug 16, 2025

Cellebrite DI Announces Shareholder Meeting Amidst Strategic Growth and Leadership Changes - The Globe and Mail

Aug 16, 2025

Cellebrite DI schedules annual general meeting for September 19 By Investing.com - Investing.com Canada

Aug 15, 2025

Cellebrite DI schedules annual general meeting for September 19 - Investing.com

Aug 15, 2025

Cellebrite DI Second Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance

Aug 15, 2025

Super League, Terawulf, Cellebrite Dominate Stocktwits Retail Chatter Among Tech Stocks: Find Out Why - Investing.com India

Aug 15, 2025

Cellebrite shares rise 1.77% premarket after appointing Thomas E. Hogan as CEO and reporting Q2 revenue beat. - AInvest

Aug 15, 2025